Page last updated: 2024-08-17

carbostyril and Anterior Horn Cell Disease

carbostyril has been researched along with Anterior Horn Cell Disease in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Pirmohamed, M	1
Boyce, S; Carlson, E; Hill, RG; Martin, JE; Rupniak, NM; Webb, JK	1

Other Studies

2 other study(ies) available for carbostyril and Anterior Horn Cell Disease

Article	Year
Nucleic acid based therapies: developing frontier for precision medicine. BMJ (Clinical research ed.), 2018, 01-23, Volume: 360 Topics: Adenoviridae; Aminophenols; Chloride Channel Agonists; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Genetic Therapy; Genomics; Hemophilia A; Humans; Molecular Targeted Therapy; Motor Neuron Disease; Mutation; Nucleic Acids; Oligonucleotides, Antisense; Precision Medicine; Quinolones; United Kingdom	2018
Onset and progression of motor deficits in motor neuron degeneration (mnd) mice are unaltered by the glycine/NMDA receptor antagonist L-701,324 or the MAO-B inhibitor R(-)-deprenyl. Experimental neurology, 1999, Volume: 155, Issue:1 Topics: Animals; Disease Progression; Excitatory Amino Acid Antagonists; Female; Male; Mice; Mice, Mutant Strains; Monoamine Oxidase Inhibitors; Motor Activity; Motor Neuron Disease; Nerve Degeneration; Quinolones; Selegiline; Stereoisomerism	1999

Article

Year

Nucleic acid based therapies: developing frontier for precision medicine.

BMJ (Clinical research ed.), 2018, 01-23, Volume: 360

Topics: Adenoviridae; Aminophenols; Chloride Channel Agonists; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Genetic Therapy; Genomics; Hemophilia A; Humans; Molecular Targeted Therapy; Motor Neuron Disease; Mutation; Nucleic Acids; Oligonucleotides, Antisense; Precision Medicine; Quinolones; United Kingdom

2018

Onset and progression of motor deficits in motor neuron degeneration (mnd) mice are unaltered by the glycine/NMDA receptor antagonist L-701,324 or the MAO-B inhibitor R(-)-deprenyl.

Experimental neurology, 1999, Volume: 155, Issue:1

Topics: Animals; Disease Progression; Excitatory Amino Acid Antagonists; Female; Male; Mice; Mice, Mutant Strains; Monoamine Oxidase Inhibitors; Motor Activity; Motor Neuron Disease; Nerve Degeneration; Quinolones; Selegiline; Stereoisomerism

1999